Two-Week Prednisone Taper Schedule for a 70-kg Adult
Begin tapering 15 days after disease control is achieved, reducing the initial dose in small decrements at appropriate intervals, with the goal of reaching the lowest effective maintenance dose. 1
Initial Dosing Context
For a 70-kg adult with controlled skin rash (assuming bullous pemphigoid or similar dermatologic condition), the starting dose would typically be:
- 0.5-0.75 mg/kg/day (35-52.5 mg daily for 70 kg) for extensive disease 1
- Lower doses (0.5-1 mg/kg) for milder presentations 2
Two-Week Taper Protocol
The FDA label and European guidelines provide the framework for tapering 3, 1:
Week 1 (Days 1-7):
- Reduce by approximately 25% of the initial dose
- Example: If starting at 40 mg daily → reduce to 30 mg daily
- Administer as single morning dose before 9 AM to minimize HPA axis suppression 3
Week 2 (Days 8-14):
- Further reduce by another 25% of the Week 1 dose
- Example: 30 mg → reduce to 20-25 mg daily
- Continue single morning administration
Critical Considerations
Timing of Taper Initiation:
- Do not begin tapering until disease control is achieved (no new lesions, healing of existing lesions) 1
- The 15-day post-control timeframe is evidence-based (Level 1 evidence) 1
Monitoring for Relapse: Watch for these specific signs during taper 1:
- New blisters, eczematous lesions, or urticarial plaques
- Large lesions (>10 cm) not healing within 1 week
- Extension of established lesions
- Daily pruritus returning
If Relapse Occurs:
- Immediately increase back to the previous effective dose 1
- Do not continue tapering until control is re-established
Important Caveats
Avoid Abrupt Discontinuation: The FDA label explicitly warns against stopping prednisone abruptly after prolonged use 3. A two-week taper is appropriate only if:
- Total treatment duration has been relatively short (weeks, not months)
- The patient has not been on high doses for extended periods
- For severe contact dermatitis (like rhus/poison ivy), a 2-3 week taper is specifically recommended to prevent rebound 4
Adrenal Suppression Risk:
- Prednisone produces adrenocortical suppression for 1.25-1.5 days per dose 3
- Patients on doses >20 mg/day for >2 weeks are at risk for HPA axis suppression 1
- Consider stress-dose coverage if the patient experiences acute illness during or shortly after taper
Alternative Approach - Alternate Day Therapy: If a two-week taper proves too rapid, consider transitioning to alternate-day dosing rather than continuing daily administration, as this minimizes HPA suppression while maintaining therapeutic effect 3.
Disease-Specific Modification: The evidence strongly suggests that for bullous pemphigoid specifically, the optimal taper extends 4-12 months, not 2 weeks 1. A rapid 2-week taper would only be appropriate for acute, self-limited conditions like severe contact dermatitis 4 or short-course treatment of other inflammatory conditions.